Climb Bio (CLYM) Other Non-Current Assets (2020 - 2026)

Climb Bio's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Other Non-Current Assets rose 576.99% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 576.99% YoY) and the FY2025 annual result came in at $1.5 million, up 9462.5% from the prior year.
• Other Non-Current Assets was $1.5 million for Q1 2026 at Climb Bio, roughly flat from $1.5 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.6 million in Q2 2022 and bottomed at $15000.0 in Q2 2023.
• A 5-year average of $853187.5 and a median of $505500.0 in 2022 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets tumbled 99.68% — and 2025, when it surged 9462.5%.
• Climb Bio's Other Non-Current Assets stood at $456000.0 in 2022, then plunged by 96.71% to $15000.0 in 2023, then grew by 6.67% to $16000.0 in 2024, then jumped by 9462.5% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
• Business Quant data shows CLYM's Other Non-Current Assets at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.